OXIDANT-ANTIOXIDANT BALANCE IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: EVALUATION OF THE ROLE OF ALPHA-TOCOPHEROL IN TREATMENT by NADEEM, AHMED
Abstract
Our first aim was to test the hypothesis of oxidative stress in asthmatics. Therefore, oxidant-antioxidant balance between stable asthma and HNC was compared. A wide array of parameters related to oxidative stress and antioxidant status were selected in blood to present a complete picture. Whole blood was assayed for total glutathione, leukocytes for superoxide generation, plasma for sulfhydryls, lipid peroxides, carbonyls, total nitrates and nitrites, GSH-Px activity, total antioxidant capacity and red cells for SOD, catalase and GSH-Px activities. Results of the study showed that there were gross disturbances in the balance in asthmatic patients as compared to HNC. Leukocyte superoxide anion generation and red cell superoxide dismutase activity was increased whereas red cell glutathione peroxidase and catalase activities were decreased in asthmatics as compared to HNC. Total blood glutathione was also found to be increased in asthmatics as compared to HNC. In plasma, lipid peroxides, total nitrates and nitrites(NOx), total protein carbonyls and GSH-Px were increased whereas total protein sulfhydryls and total antioxidant capacity measured as ferric reducing antioxidant power were decreased in asthmatics as compared to HNC. Furthemore, asthma categorised according to disease severity revealed that severe persistent asthmatics had the highest levels of leukocyte superoxide generation and plasma lipid peroxides whereas they had the lowest plasma antioxidant . Relationship of FEV1% predicted with different study parameters showed that leukocyte superoxide generation, plasma lipid peroxides, total blood glutathione were negatively correlated whereas red cell GSH-Px and plasma FRAP were positively correlated with FEV1% predicted Oxidant-antioxidant balance during acute exacerbations of asthma was also compared with that in stable asthmatics. Plasma total antioxidant capacity and total protein sulfhydryls were found to be decreased whereas lipid peroxides were increased in acute asthma as compared to stable patients. No significant difference was found in plasma GSH-Px, protein carbonyls and NOx between acute asthma and stable patients. Red cell SOD, GSH-Px and catalase activities ,superoxide anion release from leukocytes and total blood glutathione were also found to be similar between the two groups. To investigate the effect of supplementation of vitamin E with treatment , a randomized double-blind, placebo-controlled study was undertaken and its role was evaluated on endogenous blood oxidant-antioxidant balance in asthmatic patients. Patients were divided into two groups: a) Placebo group, patients receiving standard therapy of inhaled corticosteroids (beclomethasone dipropionate, 800ug/day) and placebo capsules and b) Vitamin E-supplemeted group, patients receiving standard therapy of inhaled corticosteroids plus capsules of 400 I.U. vitamin E twice daily. Venous blood was drawn on day 1 as baseline, then again after 8 weeks of respective treatments. Standard therapy as well vitamin E-supplemeted group had lower levels of superoxide anion generation from the baseline. Plasma GSH-Px was increased in standard therapy group whereas no difference was found in plasma GSH-Px from baseline in vitamin E-supplemeted group. Plasma lipid peroxides were increased and total antioxidant capacity was decreased in standard therapy group whereas vitamin E -supplemeted group had significantly lower levels of lipid peroxides and higher total antioxidant capacity. Total blood glutathione was also decreased in standard therapy group whereas no significant difference was found in vitamin E-supplemeted group. Plasma NOx were decreased in standard therapy group whereas they were increased in vitamin E-supplemeted group. Plasma protein sulfhydryls and red cell SOD levels were increased in standard therapy group, while there was no change in the levels of red cell SOD, the levels of the former was also increased in vitamin E-supplemeted group. No significant difference was found in plasma protein carbonyls and red cell catalase in either standard therapy group or vitamin E-supplemeted group. Plasma vitamin E levels increased more than two fold in vitamin E-supplemeted group but no change was observed in standard therapy group. There was significant improvement in FEV1% predicted in both the groups after 8 weeks of respective treatments but vitamin E-supplemeted group had greater degree of improvement in terms of % increase from baseline. 
Oxidant-antioxidant balance in COPD & effect of vitamin E supplementation Oxidant-antioxidant balance was also assessed in COPD patients and compared with age-matched healthy non-smoking controls (HNC). The changes that were found were on similar lines to that we observed in the case asthmatics. Superoxide anion generation, plasma lipid peroxides and total protein carbonyls were found to increased whereas plasma sulfhydryls and total antioxidant capacity were found to be decreased in COPD patients when compared with HNC. Red cell SOD and plasma GSH-Px activities were increased whereas red cell GSH-Px was decreased in COPD patients as compared to HNC. Red cell catalase activity and plasma NOx were similar between the two groups which were decreased and increased significantly in the case of asthmatics respectively. Total blood glutathione was also increased in COPD patients as compared to HNC. Patients grouped according to severity as stage II and stage III showed that the latter group had significantly decreased levels of total plasma antioxidants and increased total blood glutathione as compared to the former group. Relationship of FEV1% predicted with different study parameters revealed that total blood glutathione had negative whereas total antioxidant capacity had positive correlations with FEV1% predicted. All other parameters didn't have any relationship with severity of airway obstruction. 
Further, comparison of the acute patients of COPD with stable patients revealed that red cell antioxidants were increased. Red cell SOD, GSH-Px and total blood glutathione were increased in acute patients as compared to stable group. All of these three intracellular antioxidants were found to be similar in the two groups of acute and stable asthmatics. Plasma lipid peroxides were higher and total antioxidant capacity was lower in acute patients as compared to stable group. Plasma protein sulfhydryls, protein carbonyls ,NOx and GSH-Px were similar between the two groups. Red cell catalase activity as well as leukocyte superoxide production was also similar between the two groups. A randomized double-blind controlled study was undertaken to evaluate the role of exogenous supplementation of vitamin E with treatment for eight weeks on endogenous oxidant-antioxidant balance in COPD patients. Patients were divided into two groups: a) Placebo group, patients receiving standard therapy of inhaled bronchodilators and placebo capsules and b) Vitamin E-supplemeted group, patients receiving standard therapy of inhaled bronchodilators plus capsules of 400 I.U. vitamin E twice daily). Venous blood was drawn on day 1 as baseline, then again after 8 weeks of respective treatments. The study revealed that leukocyte superoxide generation was decreased in both standard therapy group and vitamin E-supplemeted group. Standard therapy group had increased plasma GSH-Px activity and lipid peroxides and decreased total blood glutathione, whereas vitamin E-supplemeted group had significantly augmented levels of total blood glutathione. Vitamin E-supplemeted group also had increased levels of red cell catalase and total plasma protein sulfhydryls whereas no effect was seen in standard therapy group. Plasma NOx decreased in standard therapy group whereas no effect was seen in vitamin E-supplemeted group. No significant difference was found in red cell SOD and GSH-Px and plasma total antioxidant capacity in either standard therapy or vitamin E-supplemeted group. Plasma vitamin E levels increased more than two fold after 8 weeks of treatment in vitamin E-supplemeted group but no difference was seen in standard therapy group. There was a marginal significant improvement in FEV1% predicted in both the groups after 8 weeks of respective treatments. 
From our studies, the following conclusions may be drawn: 1. There is increased oxidative stress and marked alterations in antioxidants in stable asthmatics. Both intracellular as well extracellular antioxidants are affected in stable disease condition. Patients with severe persistent asthma have the highest degree of superoxide generation from leukocytes and plasma lipid peroxides whereas they have the lowest plasma antioxidant capacity indicating that as the severity of the disease increases, oxidative stress also increases 2. Only extracellular antioxidants are depleted in acute patients as compared to stable ones. It is likely that extracellular antioxidants are the first line of defense and are thus depleted in acute state as well as when the severity of the disease increases i.e. severe persistent asthma. 3. The significant negative correlations of leukocyte superoxide production , plasma lipid peroxides and total blood glutathione and positive correlations with plasma FRAP and red cell GSH-Px with FEV1% predicted suggest that blood oxidant-antioxidant balance may be a good additional tool to measure the severity of the disease in asthmatics. 4. Vitamin E supplementation increases extracellular antioxidants to restore the deficit induced by oxidative stress in asthmatic patients. 5. In COPD , there is a widespread oxidant-antioxidant imbalance. There is marked increase in oxidant load and levels of antioxidants are perturbed. Both intracellular as well extracellular antioxidants are equally affected in stable disease condition. Stage III patients had lower plasma antioxidant capacity and higher levels of total blood glutathione as compared to stage II patients. 6. Both intracellular as well as extracellular antioxidants are important determinants of severity in COPD. 7. Extracelluar redox buffer representing total plasma antioxidants and intracellular redox buffer representing total blood glutathione are positively and negatively correlated with FEV1% predicted respectively, thus making them good predictors of the severity of the disease in COPD. 8. Vitamin E supplementation in the case of COPD up regulates mainly intracellular antioxidants to restore the balance perturbed by oxidative stress. 9. Thus, vitamin E, the major lipid-soluble antioxidant may have a role as an adjunct therapeutic agent along with respective standard therapy in both asthma and COPD patients to improve antioxidant screen thus reducing oxidative stress and providing greater protection against inflammation. 


